PHIBRO ANIMAL HEALTH CORP Operating Income Loss

Quick Answer

PHIBRO ANIMAL HEALTH CORP reported Operating Income Loss of $110.47 million for the year ending 2025.

  • PHIBRO ANIMAL HEALTH CORP showed an increase of +107.2% in Operating Income Loss from 2024 to 2025.
  • This data is from PHIBRO ANIMAL HEALTH CORP's annual report (Form 10-K), filed with the SEC on August 27, 2025.
  • XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 14 years of available data (2012 to 2025), PHIBRO ANIMAL HEALTH CORP's Operating Income Loss has grown by 124.0%.
  • Historical annual values: Fiscal year 2025: $110.47 million | Fiscal year 2024: $53.32 million | Fiscal year 2023: $71.85 million | Fiscal year 2022: $78.99 million | Fiscal year 2021: $74.87 million | Fiscal year 2020: $69.19 million | Fiscal year 2019: $83.23 million | Fiscal year 2018: $98.93 million | Fiscal year 2017: $97.93 million | Fiscal year 2016: $85.74 million | Fiscal year 2015: $87.67 million | Fiscal year 2014: $63.79 million | Fiscal year 2013: $56.73 million | Fiscal year 2012: $49.33 million.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: